Medistem, Inc. Merger Litigation (OTC Markets: MEDS)
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Medistem, Inc. - MEDS
BALA CYNWYD, January 8, 2013 /PR Newswire/ –Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Medistem, Inc. (“Medistem” or the “Company”) (OTC Markets –MEDS-News) relating to the proposed acquisition Intrexon Corporation. (“Intrexon”).
Under the terms of the acquisition, Medistem shareholders will receive only $0.27 in cash and $1.08 worth of Intrexon stock for each share of Medistem stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Medistem for not acting in the Company’s shareholders' best interests in connection with the sale process. The transaction may undervalue the Company and will result in a loss or no gain for many long term Medistem shareholders. The transaction only values Medistem at $26 million. Medistem stock traded above the sale price at $2.68 per share as recently as September 23, 2013 and traded at $2.98 on March 21, 2012.
If you own shares of Medistem common stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
To Join the Medistem, Inc. Litigation
Fill out this form
The complaint is unavailable at this time